Researchers develop new approach to predict immunotherapy response in breast cancer patients

Breast Cancer News

Researchers develop new approach to predict immunotherapy response in breast cancer patients
CancerImmunotherapyBiomarker
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 82 sec. here
  • 15 min. at publisher
  • 📊 Quality Score:
  • News: 78%
  • Publisher: 71%

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

Johns Hopkins Medicine Oct 29 2024 The work by computational scientists and clinicians was published Oct . 28 in the Proceedings of the National Academy of Sciences.

Unfortunately, existing predictive biomarkers have limited accuracy in identifying patients who will benefit from immunotherapy. Moreover, a large-scale assessment of characteristics that predict treatment response would require the collection of tumor biopsies and blood samples from many patients and would involve performing several assays, which is very challenging."

Using the partially synthetic data produced by the virtual clinical trial, researchers assessed the performance of 90 biomarkers alone and in double, triple and quadruple combinations. They found that measurements from tumor biopsies or blood samples taken before the start of treatment, called pretreatment biomarkers, had limited ability to predict treatment outcomes.

Related StoriesTo validate the findings, investigators performed a virtual clinical trial with patients selected based on change in tumor diameter at two weeks after the start of treatment. "The simulated response rates increased more than two-fold -; from 11% to 25% -; which is quite remarkable," Arulraj says. "This emphasizes the potential for noninvasive biomarkers as an alternative, in cases where collecting tumor biopsy samples is not feasible.

Previously, the team used an in-house modeling framework and developed a computational model with a special focus on late-stage breast cancer where the tumor has already spread to various parts of the body. This was published in Science Advances last year. The team employed data from several clinical and experimental studies to develop and thoroughly validate this computational model.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Cancer Immunotherapy Biomarker Blood Clinical Trial Immune System Medicine OCT Oncology Ph Research Tumor

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Papa Johns and Tabasco handing gamers free Call of Duty bundlesPapa Johns and Tabasco handing gamers free Call of Duty bundlesAll you need to do is find the Vaults
Read more »

15 breathtaking photos show construction of St Johns Beacon15 breathtaking photos show construction of St Johns BeaconNicknamed Radio City Tower, Bauer stations announced it is leaving the landmark
Read more »

Former Coronation Street star Melissa Johns admits her 'heart is full' as she marries long-term...Former Coronation Street star Melissa Johns admits her 'heart is full' as she marries long-term...The soap actress, 34, who played Imogen Pascoe until 2019, married long-term partner Hampton on Friday.
Read more »

DeAndre Hopkins: Kansas City Chiefs acquire wide receiver from Tennessee Titans in blockbuster tradeDeAndre Hopkins: Kansas City Chiefs acquire wide receiver from Tennessee Titans in blockbuster tradeDeAndre Hopkins is joining the Kansas City Chiefs from the Tennessee Titans in a blockbuster trade for the reigning Super Bowl champions.
Read more »

Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attackResearchers develop first-of-its-kind therapy to enhance heart repair after a heart attackScientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind experimental therapy that has the potential to enhance heart repair following a heart attack, preventing the onset of heart failure.
Read more »

Electric skin patch offers drug-free solution to bacterial infectionsElectric skin patch offers drug-free solution to bacterial infectionsUsing a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. For the first time, researchers designed a skin patch that uses imperceptible electric currents to control microbes.
Read more »



Render Time: 2025-08-27 15:13:46